All Articles

Beyond the polish, the rise of companies like Pudu Robotics reveals the real story: an AI-driven digital infrastructure is quietly rewiring our cities.

After securing a $114M financing deal, Pyxis Oncology has extended its runway into 2027, putting all focus on upcoming MICVO data for head and neck cancer.

A private equity firm's acquisition of a wastewater company reveals a deeper story about water scarcity, reshoring, and the systems we need to thrive.

Lurie Children's new facility is more than a pharmacy; it's a look into a new system where hospitals integrate business and care to survive and thrive.

New research shows soaring housing costs are pushing residents out, creating an urgent economic and social challenge that state leaders are scrambling to address.

AM Best's top-tier rating affirms National Life Group's market strength, but a deeper look reveals a strategy balancing aggressive growth with complex challenges.

XbotGo's landmark deal with Best Buy isn't just a retail win; it's a signal that AI is finally becoming the ultimate tool for the modern family.

Curis secures a crucial, albeit small, $5.6M funding lifeline. Will it be enough to push its promising cancer drug through trials before the clock runs out?

Despite a sharp performance dip in July driven by an AI stock selloff, investors continue to pour capital into hedge funds for the seventh straight month.

XChange TEC's plan to acquire AI firm First Cycle reveals a bold strategy to automate insurance from the ground up, moving beyond distribution to core operations.

As CEO Gareth Sheridan takes the stage, his company's abuse-deterrent tech, AVERSA™, promises a new front in the opioid crisis. But can it deliver?

With a blockbuster IPO and dazzling growth, Bending Spoons looks unstoppable. But a closer look reveals a high-stakes strategy built on massive debt.

SPXChart's new platform promises to show everyday traders the market's hidden plumbing. But can it truly level the playing field against Wall Street's titans?

Kolibri Global Energy shatters records with a 109% revenue jump, but the real story lies underground with a new strategy to unlock vast, untapped reserves.

Radian has bet its future on a massive strategic pivot. New CEO Mike Weinbach brings a mortgage tech playbook to a complex global insurance game. Will it work?

A German research award for a Chinese tech firm may seem niche, but it's a critical signal. DoGo Power's technology is a direct answer to a looming crisis.

A Hong Kong wet trades firm is buying into a European spa distributor. A bold strategic leap or a risky diversification into an unfamiliar market?

Opendoor secured $440M in zero-interest capital while buying back stock. Is this a financial masterstroke paving a path to profit or a complex bet on a risky future?

YETI's Q2 profits surged, but a one-time tariff refund clouds the picture. We unpack the real story behind its global expansion and diversification strategy.

Tidewater Midstream's record Q2 results reveal a powerful strategy: leveraging renewable fuel growth to slash debt and boost guidance. A deep dive.